Metrifonate for Alzheimer's disease - Is the next cholinesterase inhibitor better?

被引：19

作者：

Knopman, DS ^{[1
]}

机构：

[1] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA

来源：

NEUROLOGY | 1998年 / 50卷 / 05期

关键词：

D O I：

10.1212/WNL.50.5.1203

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1203 / 1205

页数：3

共 25 条

[1] Anand R., 1996, Neurobiology of Aging, V17, pS87, DOI 10.1016/S0197-4580(96)80351-4
[2] EFFECTS OF METRIFONATE, A LONG-ACTING CHOLINESTERASE INHIBITOR, IN ALZHEIMER-DISEASE - REPORT OF AN OPEN TRIAL
BECKER, RE
COLLIVER, J
ELBLE, R
FELDMAN, E
GIACOBINI, E
KUMAR, V
MARKWELL, S
MORIEARTY, P
PARKS, R
SHILLCUTT, SD
UNNI, L
VICARI, S
WOMACK, C
ZEC, RF
[J]. DRUG DEVELOPMENT RESEARCH, 1990, 19 (04) : 425 - 434
[3] Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease
Bodick, NC
Offen, WW
Levey, AI
Cutler, NR
Gauthier, SG
Satlin, A
Shannon, HE
Tollefson, GD
Rasmussen, K
Bymaster, FP
Hurley, DJ
Potter, WZ
Paul, SM
[J]. ARCHIVES OF NEUROLOGY, 1997, 54 (04) : 465 - 473
[4] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
BRAAK, H
BRAAK, E
[J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
[5] Donepezil
Bryson, HM
Benfield, P
[J]. DRUGS & AGING, 1997, 10 (03) : 234 - 239
[6] THE NEUROPSYCHIATRIC INVENTORY - COMPREHENSIVE ASSESSMENT OF PSYCHOPATHOLOGY IN DEMENTIA
CUMMINGS, JL
MEGA, M
GRAY, K
ROSENBERGTHOMPSON, S
CARUSI, DA
GORNBEIN, J
[J]. NEUROLOGY, 1994, 44 (12) : 2308 - 2314
[7] TACRINE
DAVIS, KL
POWCHIK, P
[J]. LANCET, 1995, 345 (8950) : 625 - 630
[8] Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33
[9] Butyrylcholinesterase in the life cycle of amyloid plaques
Guillozet, AL
Smiley, JF
Mash, DC
Mesulam, MM
[J]. ANNALS OF NEUROLOGY, 1997, 42 (06) : 909 - 918
[10] Predictors of time to institutionalization of patients with Alzheimer's disease: The CERAD experience .17.
Heyman, A
Peterson, B
Fillenbaum, G
Pieper, C
[J]. NEUROLOGY, 1997, 48 (05) : 1304 - 1309

← 1 2 3 →